Drug recall · July 2, 2025
DOBUTamine Injection recall
Why: Discoloration; discolored solution from cracked vials
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
DOBUTamine Injection, USP, 250 mg/20 mL (12.5 mg/mL), 20 mL per Single-dose Vial, carton of 10 Fliptop Vials, Rx only, For Intravenous Use Only, Made in Italy, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. NDC Carton: 0409-2344-02; NDC Vial: 0409-2344-62
- Lots / codes
Lot KA5023, exp 02/28/2026
- Quantity
- 98,410 vials
- Company
- Pfizer Inc., New York, NY
- Distribution
- Nationwide in the USA
- Initiated
- May 28, 2025 · Voluntary: Firm initiated
- Classified
- June 23, 2025
- Reported
- July 2, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Dobutamine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.